Others have shown that THBS1 peptide antagonist prevented the progression of cardiac fibrosis and improved cardiac function by reducing TGF-β activity in a rat model of diabetic cardiomyopathy [48]. This evidence concerns the gene THBS1 and diabetic cardiomyopathy.